EnginZyme
- Company typePrivate
- Founded2014
- HeadquartersStockholm, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
EnginZyme firmographics
Firmographics- Name
- EnginZyme
- Legal name
- EnginZyme AB
- Website
- https://enginzyme.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
EnginZyme industry classification
Industry- Product category
- Industrial Biotechnology / Biocatalysis
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)
- akta.pro secondary industries
- Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)
Keywords
Where EnginZyme is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
EnginZyme business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Biocatalyst Products: Sale of turnkey biocatalysts including EziG-CalB and EziG-Lip, as well as specialty ingredients like Pseudouridine (cGMP grade). Products available for off-the-shelf solutions or customized development.
- Biocatalysis Services: Full-stack service offerings including feasibility studies, enzyme discovery and engineering, catalyst development and customization, and process development from lab to pilot scale.
- Bespoke Bioprocess Development: Customized bioprocess development using proprietary platform for efficient, sustainable, and scalable synthesis of molecules. Process development from discovery to scale-up.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
EnginZyme product offering
Product offeringCore offering
EnginZyme sells a proprietary cell-free biomanufacturing platform built on patented EziG enzyme immobilization technology, offering EziG-CalB and EziG-Lip immobilized biocatalysts for esterification, transesterification, and food oil interesterification, plus cGMP-grade Pseudouridine as a specialty ingredient for mRNA vaccines. The platform is delivered to enterprise customers in food, pharma, cosmetics, and industrial chemicals through both off-the-shelf catalyst/ingredient sales and full-stack services covering feasibility studies, enzyme discovery and engineering, catalyst customization, and lab-to-pilot scale-up.
Product overview
EnginZyme offers a comprehensive product portfolio centered on its proprietary cell-free biomanufacturing platform. The core offering includes EziG® branded biocatalysts (EziG®-CalB for esterification/transesterification reactions and EziG®-Lip for food oil interesterification), plus Pseudouridine as a specialty ingredient for mRNA vaccine manufacturing. These products are complemented by full-service offerings including feasibility studies, enzyme discovery and engineering, and catalyst customization services. The platform enables customers to replace traditional chemical catalysts with enzymes for sustainable manufacturing across cosmetics, food, pharma, and industrial chemicals sectors.
Differentiator
Problem solved
Functional benefit
Brands
- EziG: World's most efficient enzyme immobilization technology enabling creation of tailored, stable solid biocatalysts for multistep enzymatic reactions.
- EziG-CalB
- EziG-Lip
- Thunderdome
- Thunder Dream
Products and services
- EziG-CalB Biocatalyst Immobilized Candida antarctica lipase B catalyst designed for efficient esterification, transesterification, and amidation reactions, offering high selectivity and stability for sustainable synthesis of cosmetic ingredients, emollients, and specialty esters.
- EziG-Lip Biocatalyst Next-generation immobilized lipase catalyst for batch enzymatic interesterification (bEIE) of fats and oils, enabling sustainable production of high-quality oils and fats without harsh chemicals or unwanted by-products, combining enzymatic interesterification benefits with batch processing flexibility.
- Pseudouridine Specialty Ingredient Critical precursor for mRNA nucleotides and a key ingredient in mRNA COVID-19 vaccines, manufactured under cGMP using a green, scalable enzymatic process with >99 wt.% purity specification (CAS Number 1445-07-4, EC Number 978-484-6).
- Feasibility Study Service Technical and economic assessment of applying biocatalysis to customer chemistry, providing consultation on enzyme families and early process development with a clear technical path forward and risk/cost briefing.
- Enzyme Discovery and Engineering Service Service that finds and refines the right enzyme for customer needs, from initial discovery to optimization, delivering a curated panel of wild-type enzyme sequences or targeted in-house enzyme design, screening, and validation.
- EziG Screening and Customization Service Selection and customization of EziG carrier materials to match customer process requirements, including catalyst development, application testing, automated formulation screening, and cascade optimization for both batch and continuous operations.
- N1-methylpseudouridine-5'-triphosphate (m1PsiTP) Manufacturing Process Scalable hybrid manufacturing process for N1-methylpseudouridine-5'-triphosphate (m1PsiTP), combining selective chemical methylation with a multi-enzyme phosphorylation cascade to deliver a critical mRNA vaccine and therapy ingredient at kilogram scale in an animal-free, cGMP-compliant European facility.
- Cell-Free Biomanufacturing Platform Proprietary cell-free biomanufacturing platform combining patented EziG enzyme immobilization technology with process engineering for sustainable industrial chemical synthesis, enabling biocatalysis deployment using traditional chemical manufacturing tools without living organisms.
Quantifiable outcome
- Energy savings: 0% energy compared with traditional catalysis (referenced on company page as stated metric)
- +3 more outcomes
Companies that use EnginZyme
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles4 records
EnginZyme technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature10 records
EnginZyme partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- AGC Inc.coreCollaboration to create scalable process for N1-methylpseudouridine-5'-triphosphate (m1PsiTP), a key mRNA vaccine and therapy ingredient. Combines selective chemical methylation with multi-enzyme phosphorylation cascade. Manufacturing planned for Europe, animal-free, cGMP compliant. Kilogram-scale manufacturing targeted for 2026.
- Ajinomoto Bio-Pharma ServicescoreCDMO partnership for scale-up and cGMP manufacturing of pseudouridine at industrial scale. Developed patented process to manufacture pseudouridine for mRNA vaccines using biocatalysis. Already synthesized enough pseudouridine for more than 500 million vaccine doses in cGMP-compliant facility.
- Tetra PakcoreStrategic collaboration to bring sustainable and economically sound solutions to food and beverage industry. Companies leveraging respective strengths to find ways to improve food production, such as turning food waste (acid whey) into valuable ingredients. Tetra Pak integrating EnginZyme's biotechnology directly into product or waste-stream lines for easy scaling.
- BungecoreIndustry partnership for enzymatic interesterification of food oils. Customizing processes for low-trans or trans-fat-free margarines and shortenings. Working to cut costs and create purer, safer, more sustainable products without extensive downstream processing.
Scale indicators11 records
Recent moves7 records
Expansion highlights6 records
EnginZyme competitors and assessment
Company assessmentDirect peers
- Codexis: Codexis engineers novel enzymes and biocatalysts for pharmaceutical and industrial applications using its proprietary CodeEvolver platform. Closest direct peer to EnginZyme given shared focus on protein engineering for sustainable chemical manufacturing and pharma intermediates.
- AB Enzymes: Specialty enzyme producer serving food, beverage, and industrial sectors. Comparable to EnginZyme's EziG-Lip and food oil applications; both supply enzymes as products to industrial processors.
- Carbios: French biotech developing enzymatic processes for plastics recycling and PET depolymerization. Comparable in using engineered enzymes as industrial process catalysts with a sustainability positioning similar to EnginZyme.
Broad incumbents
- Novonesis (formerly Novozymes): Global leader in industrial enzymes with massive scale across food, agriculture, and bioenergy. Competes broadly with EnginZyme in food oil processing and industrial biocatalysis, though focused on secreted bulk enzymes versus EnginZyme's cell-free immobilized approach.
- Ginkgo Bioworks: Synthetic biology platform company developing engineered organisms and enzymes for industrial customers. Differs in cell-based approach but shares the thesis of biology-as-manufacturing and serves overlapping end markets.
- DSM-firmenich: Diversified ingredients company with significant presence in food, personal care, and nutritional enzymes. Competes with EnginZyme in cosmetic emollients and food oil processing as part of a much broader portfolio.
Regional players
- Amano Enzyme: Japanese manufacturer of industrial enzymes for food, pharmaceutical, and diagnostic applications. Comparable product portfolio focused on lipases and specialty enzymes but with primary geographic strength in Asia rather than Europe.
Emerging players
- Bota Bio: Synthetic biology startup building a platform for sustainable biomanufacturing of chemicals and ingredients using engineered microbes. Comparable in targeting industrial customers with bio-based process alternatives, though cell-based rather than cell-free.
- Cyrus Biotechnology: Computational protein design company offering protein engineering software and services using Rosetta and other tools. Comparable in the AI/ML-driven protein design layer underlying EnginZyme's Thunderdome and Thunder Dream platforms.
Others
- Johnson Matthey: Major specialty chemicals and sustainable technologies company with catalyst and process technology divisions (including former CTO's previous employer). Adjacent rather than directly competitive, but represents the traditional catalysis infrastructure EnginZyme aims to displace with biocatalysis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
EnginZyme social profiles
Digital presenceEnginZyme compliance and trust
Trust signalCompliance4 records
EnginZyme financial estimates
Financial estimateRevenue estimate
Valuation estimate
EnginZyme leadership team
Management profileNumber of profiles
Profiles16 records
EnginZyme funding detail
Funding detailFunding overview
Funding rounds5 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EnginZyme M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EnginZyme
What does EnginZyme do?
EnginZyme sells a proprietary cell-free biomanufacturing platform built on patented EziG enzyme immobilization technology, offering EziG-CalB and EziG-Lip immobilized biocatalysts for esterification, transesterification, and food oil interesterification, plus cGMP-grade Pseudouridine as a specialty ingredient for mRNA vaccines. The platform is delivered to enterprise customers in food, pharma, cosmetics, and industrial chemicals through both off-the-shelf catalyst/ingredient sales and full-stack services covering feasibility studies, enzyme discovery and engineering, catalyst customization, and lab-to-pilot scale-up.
Is EnginZyme a public or private company?
EnginZyme is a private company. It is classified as venture growth investor backed and is currently operating.
When was EnginZyme founded?
EnginZyme was founded in 2014. It employs 11 to 50 people.
Where is EnginZyme based?
EnginZyme is headquartered in Stockholm, Sweden, in the Europe region.
How does EnginZyme make money?
Three revenue lines are on record. Biocatalyst Products are the primary driver. The others are biocatalysis Services and bespoke Bioprocess Development.
Who are EnginZyme's main competitors?
Direct peers on record are Codexis, AB Enzymes and Carbios. Broad incumbents are Novonesis (formerly Novozymes), Ginkgo Bioworks and DSM-firmenich. Amano Enzyme is listed as a regional player. Emerging players are Bota Bio and Cyrus Biotechnology. Johnson Matthey is listed as an others.
Does EnginZyme have an API?
No public API is recorded for EnginZyme.
What industry is EnginZyme in?
EnginZyme's product category is Industrial Biotechnology / Biocatalysis. Its primary akta.pro industry code is HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization), with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 541714 and its SIC code is 2834.